Effect of Tea on Endothelial Function and Ischaemia-reperfusion Injury

February 1, 2013 updated by: Radboud University Medical Center

Effect of Black Tea Consumption on Endothelial Function and Ischaemia-reperfusion Injury in Humans

Tea consumption may impact upon the decrease in endothelial function after IR-injury. However, no previous study directly examined the potential of tea to impact upon the change in endothelial function after IR-injury.

The investigators hypothesize that tea consumption counteracts endothelial damage in response to ischaemia reperfusion injury in healthy humans.

Study Overview

Status

Completed

Detailed Description

Rationale: Occlusion of an artery (causing ischemia) is a frequently reported condition, e.g. myocardial infarction, cerebral infarction or during organ transplantations. The period of ischemia will be followed by reperfusion (possibly after an operation). The ischaemic period as well as the reperfusion are both associated with damage to the tissue, including the endothelium. It is hypothesised that production of oxidative stress and reduced NO bioactivity (through increased reactive oxygen production) during ischaemia and reperfusion is involved in the development of tissue damage to the endothelium. Interventions that can prevent or attenuate endothelial dysfunction in response to ischemia-reperfusion (IR)-injury have a potential clinical relevance to prevent (complications of) cardiovascular disease.

Several studies have examined the effect of tea consumption on the endothelial function. These studies demonstrated a dose-dependent improvement of tea to improve endothelial function in healthy and diseased humans, possibly through the vasoactive effects of flavonoids, which may involve increased nitric oxide bioactivity and inhibition of NADPH oxidase. Based on the ability of flavonoids to decrease (the impact of) oxidative stress, tea consumption may also impact upon the decrease in endothelial function after IR-injury. However, no previous study directly examined the potential of tea to impact upon the change in endothelial function after IR-injury.

Objective: To examine whether tea consumption counteracts endothelial damage in response to ischaemia reperfusion injury in healthy humans.

Main study parameters: Change in endothelial function (measured with flow mediated dilation) after ischaemia reperfusion injury (induced by 20 minutes ischemia and 20 min reperfusion) with and without precedence of tea consumption.

Nature and extent of the burden and risks associated with participation, benefit and group relatedness: Non-invasive cuff occlusion is used to examine endothelial function (5-minute ischaemia) and produce the stimulus that induces ischaemia-reperfusion injury (20-minute ischaemia). This repeated cuff inflation is non-invasive and not associated with a health risk for the subject. Tea consumption is safe and, most likely, daily routine for most participants. The only difference is that this study will monitor and instruct participants regarding their tea consumption in the week preceding the tests. The volunteers will not benefit directly from participating in this study.

Study Type

Observational

Enrollment (Actual)

23

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Gelderland
      • Nijmegen, Gelderland, Netherlands, 6525 EX
        • Radboud University Nijmegen Medical Centre

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 60 years (ADULT)

Accepts Healthy Volunteers

Yes

Genders Eligible for Study

All

Sampling Method

Probability Sample

Study Population

Twenty-one volunteers, aged between 30 and 70 years, were included in our study. All subjects were healthy and free of (a history of) cardiovascular disease or obesity (BMI >30 kg/m2). Individuals were excluded if they reported a chronic or acute disease, including any kind of metabolic abnormality (such as diabetes mellitus) or cardiovascular disease. Habitual smokers (n=3) were instructed to withdraw from smoking on the day of testing. To further avoid confounding factors, the investigators also excluded individuals reporting daily intense sporting activities (>10 h/w), and/or were treated with a diet due to any reason.

Description

Inclusion Criteria:

  • Healthy volunteers : age 18-60
  • All subjects: written informed consent

Exclusion Criteria:

  • Smoking
  • History of any cardiovascular disease
  • Hypertension (in supine position: systole >140 mmHg, diastole >90 mmHg)
  • Diabetes Mellitus
  • Hyperlipidaemia (fasting total cholesterol >6.5 mmol/L)
  • Chronic use of medication known to interfere with the cardiovascular system
  • Professional athletes
  • Alcohol consumption >14 units/week
  • BMI >30 kg/m2

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
Tea
Black tea ingestion

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change in Endothelial Function after ischaemia reperfusion injury
Time Frame: three weeks
Change in endothelial function (measured with flow mediated dilation) after ischaemia reperfusion injury (induced by 20 minutes ischemia and 20 min reperfusion) with and without precedence of tea consumption
three weeks

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change in baseline flow mediated dilation after water/tea consumption
Time Frame: three weeks
Change in baseline flow mediated dilation after water/tea consumption
three weeks

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Collaborators

Investigators

  • Principal Investigator: Dick Thijssen, Dr., Radboud University Medical Centre Nijmegen
  • Principal Investigator: Maria Hopman, prof. dr., Radboud University Medical Center

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

August 1, 2011

Primary Completion (ACTUAL)

February 1, 2012

Study Completion (ACTUAL)

February 1, 2012

Study Registration Dates

First Submitted

August 6, 2012

First Submitted That Met QC Criteria

August 6, 2012

First Posted (ESTIMATE)

August 8, 2012

Study Record Updates

Last Update Posted (ESTIMATE)

February 4, 2013

Last Update Submitted That Met QC Criteria

February 1, 2013

Last Verified

July 1, 2012

More Information

Terms related to this study

Other Study ID Numbers

  • TEA-IRI
  • Tea-IR-Injury-FMD (OTHER: Radboud University Nijmegen Medical Centre)

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Ischaemia Reperfusion Injury

Subscribe